Opicapone as First-Line Strategy for the Treatment of Wearing-off in Patients with Parkinson&#39;s Disease

Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL

https://www.mdsabstracts.org/abstract/opicapone-as-first-line-strategy-for-the-treatment-of-wearing-off-in-patients-with-parkinsons-disease/

J. Ferreira; J. Lee; H. Ma; B. Jeon; W. Poewe; A. Antonini; F. Stocchi; D. Rodrigues; M. Fonesca; J. Rocha; G. Castilla-Fernández; J. Holenz; O. Rascol

Aug 9, 2024